BreastScreen Australia data 2016–2017; Quality Statement
Identifying and definitional attributes
|Metadata item type:||Quality Statement|
|Registration status:||AIHW Data Quality Statements, Endorsed 29/01/2019|
|Quality statement summary:|
Summary of Key Issues
BreastScreen Australia data are highly relevant and timely for monitoring trends in breast screening participation and the detection of invasive breast cancer and ductal carcinoma in situ (DCIS) through BreastScreen Australia. A relatively small amount of screening mammography occurs through services other than BreastScreen Australia.
BreastScreen Australia is Australia’s national, population-based breast cancer screening program and is a joint program of the Australian and state and territory governments.
The Australian Institute of Health and Welfare (AIHW) is a major national agency set up by the Australian Government under the Australian Institute of Health and Welfare Act 1987 to provide reliable, regular and relevant information and statistics on Australia's health and welfare. It is an independent corporate Commonwealth entity established in 1987, governed by a management Board, and accountable to the Australian Parliament through the Health portfolio.
BreastScreen data are available within about 6–12 months. (It can take up to 12 months for final pathology results on all breast tissue samples to be received by BreastScreen registers.) The BreastScreen Australia database cannot be fully compiled until the final jurisdiction supplies its data.
BreastScreen Australia data are published annually in the BreastScreen Australia monitoring report available on the AIHW website https://www.aihw.gov.au/reports-data/health-welfare-services/cancer-screening/overview where they can be downloaded without charge. Supplementary data tables presenting more detailed data accompany each report and these, too, are available on the AIHW website where they can be downloaded without charge.
While many concepts in the BreastScreen Australia monitoring report are easy to interpret, other concepts and statistical calculations are more complex. All concepts are explained within the body of the report presenting these data, along with footnotes to provide further details and caveats. The appendixes provide additional detail on the data sources and classifications, and on the statistical methods used.
Breast cancer screening data are highly relevant for monitoring trends in breast screening participation and the detection of invasive breast cancer and DCIS, as well as other measures of program performance such as recall to assessment rates and sensitivity measures. The data are used for many purposes by policy makers and researchers, but are supplied and analysed specifically to monitor and inform BreastScreen Australia.
All data provided by state and territory BreastScreen programs, once analysed, are supplied back for verification.
BreastScreen data are reported and published annually by the AIHW.
|Related metadata references:|
Supersedes BreastScreen Australia data 2015–2016; Quality Statement AIHW Data Quality Statements, Archived 29/01/2019
Has been superseded by BreastScreen Australia data 2017–2018; Quality Statement AIHW Data Quality Statements, Archived 01/12/2020